Literature DB >> 18537119

Regulation of the Nanog gene by both positive and negative cis-regulatory elements in embryonal carcinoma cells and embryonic stem cells.

Brian Boer1, Jesse L Cox, David Claassen, Sunil Kumar Mallanna, Michelle Desler, Angie Rizzino.   

Abstract

The transcription factor Nanog is essential for mammalian embryogenesis, as well as the pluripotency of embryonic stem (ES) cells. Work with ES cells and embryonal carcinoma (EC) cells previously identified positive and negative cis-regulatory elements that influence the activity of the Nanog promoter, including adjacent cis-regulatory elements that bind Sox2 and Oct-3/4. Given the importance of Nanog during mammalian development, we examined the cis-regulatory elements required for Nanog promoter activity more closely. In this study, we demonstrate that two positive cis-regulatory elements previously shown to be active in F9 EC cells are also active in ES cells. We also identify a novel negative regulatory region that is located in close proximity to two other positive Nanog cis-regulatory elements. Although this negative regulatory region is active in F9 EC cells and ES cells, it is inactive in P19 EC cells. Furthermore, we demonstrate that one of the positive cis-regulatory elements active in F9 EC cells and ES cells is inactive in P19 EC cells. Together, these and other studies suggest that Nanog transcription is regulated by the interplay of positive and negative cis-regulatory elements. Given that P19 appears to be more closely related to a later developmental stage of mammalian development than F9 and ES cells, differential utilization of cis-regulatory elements may reflect mechanisms used during development to achieve the correct level of Nanog expression as embryogenesis unfolds. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18537119      PMCID: PMC2614456          DOI: 10.1002/mrd.20943

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  50 in total

1.  Identification of the transactivation domain of the transcription factor Sox-2 and an associated co-activator.

Authors:  T K Nowling; L R Johnson; M S Wiebe; A Rizzino
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

2.  The co-activator p300 associates physically with and can mediate the action of the distal enhancer of the FGF-4 gene.

Authors:  Tamara Nowling; Cory Bernadt; Lance Johnson; Michelle Desler; Angie Rizzino
Journal:  J Biol Chem       Date:  2002-12-17       Impact factor: 5.157

3.  Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex.

Authors:  Mizuho Tomioka; Masazumi Nishimoto; Satoru Miyagi; Tomoko Katayanagi; Nobutaka Fukui; Hitoshi Niwa; Masami Muramatsu; Akihiko Okuda
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

4.  Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells.

Authors:  Ian Chambers; Douglas Colby; Morag Robertson; Jennifer Nichols; Sonia Lee; Susan Tweedie; Austin Smith
Journal:  Cell       Date:  2003-05-30       Impact factor: 41.582

5.  Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development.

Authors:  Yoshimi Tokuzawa; Eiko Kaiho; Masayoshi Maruyama; Kazutoshi Takahashi; Kaoru Mitsui; Mitsuyo Maeda; Hitoshi Niwa; Shinya Yamanaka
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 6.  Embryonic stem cells provide a powerful and versatile model system.

Authors:  Angie Rizzino
Journal:  Vitam Horm       Date:  2002       Impact factor: 3.421

7.  Activation of the murine type II transforming growth factor-beta receptor gene: up-regulation and function of the transcription factor Elf-3/Ert/Esx/Ese-1.

Authors:  Jae-Hwan Kim; Phillip J Wilder; Jingwen Hou; Tamara Nowling; Angie Rizzino
Journal:  J Biol Chem       Date:  2002-03-13       Impact factor: 5.157

8.  Transfection of embryonal carcinoma cells at high efficiency using liposome-mediated transfection.

Authors:  Tamara Nowling; Michelle Desler; Charles Kuszynski; Angie Rizzino
Journal:  Mol Reprod Dev       Date:  2002-11       Impact factor: 2.609

9.  The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells.

Authors:  Kaoru Mitsui; Yoshimi Tokuzawa; Hiroaki Itoh; Kohichi Segawa; Mirei Murakami; Kazutoshi Takahashi; Masayoshi Maruyama; Mitsuyo Maeda; Shinya Yamanaka
Journal:  Cell       Date:  2003-05-30       Impact factor: 41.582

10.  Multipotent cell lineages in early mouse development depend on SOX2 function.

Authors:  Ariel A Avilion; Silvia K Nicolis; Larysa H Pevny; Lidia Perez; Nigel Vivian; Robin Lovell-Badge
Journal:  Genes Dev       Date:  2003-01-01       Impact factor: 11.361

View more
  4 in total

1.  Zfp281 mediates Nanog autorepression through recruitment of the NuRD complex and inhibits somatic cell reprogramming.

Authors:  Miguel Fidalgo; Francesco Faiola; Carlos-Filipe Pereira; Junjun Ding; Arven Saunders; Julian Gingold; Christoph Schaniel; Ihor R Lemischka; José C R Silva; Jianlong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

2.  Expression of the stem cell marker, Nanog, in human endometrial adenocarcinoma.

Authors:  Xi Zhou; Yu-Ping Zhou; Guang-Rong Huang; Bao-Lan Gong; Bo Yang; Dong-Xia Zhang; Pin Hu; Sheng-Rong Xu
Journal:  Int J Gynecol Pathol       Date:  2011-05       Impact factor: 3.326

3.  AP-1 Gene Expression Levels May Be Correlated with Changes in Gene Expression of Some Stemness Factors in Colon Carcinomas.

Authors:  Panagiotis Apostolou; Maria Toloudi; Eleni Ioannou; Marina Chatziioannou; Eleni Kourtidou; Ioanna Vlachou; Ioannis Papasotiriou
Journal:  J Signal Transduct       Date:  2013-12-11

Review 4.  Mechanisms Regulating Stemness and Differentiation in Embryonal Carcinoma Cells.

Authors:  Gregory M Kelly; Mohamed I Gatie
Journal:  Stem Cells Int       Date:  2017-03-08       Impact factor: 5.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.